Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex

Journal of Diabetes

Volumn 3, Issue 3, 2011, Pages 238-247

  Baschal, Erin E ^a,c   Sarkar, Suparna A ^a   Boyle, Theresa A ^a   Siebert, Janet C ^b   Jasinski, Jean M ^a,d   Grabek, Katharine R ^a   Armstrong, Taylor K ^a   Babu, Sunanda R ^a   Fain, Pamela R ^a   Steck, Andrea K ^a   Rewers, Marian J ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CytoAnalytics   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Strand Scientific Intelligence Inc   (United States)

Author keywords

Genetic association studies; Major histocompatibility complex; Type 1 diabetes

Indexed keywords

LEUKOCYTE ANTIGEN;

ARTICLE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE REPLICATION; GENETIC RISK; HAPLOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE;

BASE SEQUENCE; DIABETES MELLITUS, TYPE 1; DNA REPLICATION; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC LOCI; GENOTYPE; HAPLOTYPES; HLA ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TELOMERE; UBIQUITINS;

EID: 80051815907     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2011.00131.x     Document Type: Article

References (45)

1. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007; 447: 661-78.
2. Cooper JD, Smyth DJ, Smiles AM et al. Meta-analysis of genome-wide association study data identifies additional Type 1 diabetes risk loci. Nat Genet. 2008; 40: 1399-401.
3. Concannon P, Erlich HA, Julier C et al. Type 1 diabetes: Evidence for susceptibility loci from four genome-wide linkage scans in 1, 435 multiplex families. Diabetes. 2005; 54: 2995-3001.
4. Steck AK, Baschal EE, Jasinski JM et al. rs2476601 T allele (R620W) defines high-risk PTPN22 Type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype. Genes Immun. 2009; 10(Suppl. 1): S21-6.
5. Pugliese A, Zeller M, Fernandez A Jr et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for Type 1 diabetes. Nat Genet. 1997; 15: 293-7.
6. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993; 52: 506-16.
7. Bottini N, Musumeci L, Alonso A et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004; 36: 337-8.
8. Zheng W, She JX. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and Type 1 diabetes. Diabetes. 2005; 54: 906-8.
9. Qu HQ, Bradfield JP, Grant SF, Hakonarson H, Polychronakos C. Remapping the Type I diabetes association of the CTLA4 locus. Genes Immun. 2009; 10(Suppl. 1): S27-32.
10. Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003; 423: 506-11.
11. Smyth DJ, Cooper JD, Bailey R et al. A genome-wide association study of nonsynonymous SNPs identifies a Type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet. 2006; 38: 617-9.
12. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of Type 1 diabetes. Nat Genet. 2007; 39: 857-64.
13. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against Type 1 diabetes. Science. 2009; 324: 387-9.
14. Vella A, Cooper JD, Lowe CE et al. Localization of a Type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet. 2005; 76: 773-9.
15. Qu HQ, Bradfield JP, Belisle A, Grant SF, Hakonarson H, Polychronakos C. The type I diabetes association of the IL2RA locus. Genes Immun. 2009; 10(Suppl. 1): S42-8.
16. Howson JM, Walker NM, Smyth DJ, Todd JA. Analysis of 19 genes for association with Type I diabetes in the Type I Diabetes Genetics Consortium families. Genes Immun. 2009; 10(Suppl. 1): S74-84.
17. Barrett JC, Clayton DG, Concannon P et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of Type 1 diabetes. Nat Genet. 2009; 41: 703-7.
18. She JX. Susceptibility to Type I diabetes: HLA-DQ and DR revisited. Immunol Today. 1996; 17: 323-9.
19. Rewers M, Bugawan TL, Norris JM et al. Newborn screening for HLA markers associated with IDDM: Diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996; 39: 807-12.
20. Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, Erlich HA. The HLA Class I A locus affects susceptibility to Type 1 diabetes. Hum Immunol. 2002; 63: 657-64.
21. Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen Class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol. 2005; 66: 301-13.
22. Nejentsev S, Howson JM, Walker NM et al. Localization of Type 1 diabetes susceptibility to the MHC Class I genes HLA-B and HLA-A. Nature. 2007; 450: 887-92.
23. Howson JM, Walker NM, Clayton D, Todd JA. Confirmation of HLA Class II independent Type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab. 2009; 11(Suppl. 1): 31-45.
24. Baschal EE, Aly TA, Babu SR et al. HLA-DPB1*0402 protects against Type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY population. Diabetes. 2007; 56: 2405-9.
25. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA Class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet. 1996; 59: 1134-48.
26. Noble JA, Valdes AM, Thomson G, Erlich HA. The HLA Class II locus DPB1 can influence susceptibility to Type 1 diabetes. Diabetes. 2000; 49: 121-5.
27. Aly TA, Ide A, Jahromi MM et al. Extreme genetic risk for Type 1A diabetes. Proc Natl Acad Sci USA. 2006; 103: 14074-9.
28. Aly TA, Baschal EE, Jahromi MM et al. Analysis of single nucleotide polymorphisms identifies major Type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes. 2008; 57: 770-6.
29. Brown WM, Pierce J, Hilner JE et al. Overview of the MHC fine mapping data. Diabetes Obes Metab. 2009; 11(Suppl. 1): 2-7.
30. Mychaleckyj JC, Noble JA, Moonsamy PV et al. HLA genotyping in the International Type 1 Diabetes Genetics Consortium. Clin Trials. 2010; 7(Suppl.): S75-87.
31. O'Connell JR, Weeks DE. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998; 63: 259-66.
32. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin: Rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2002; 30: 97-101.
33. Raum D, Awdeh Z, Yunis EJ, Alper CA, Gabbay KH. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J Clin Invest. 1984; 74: 449-54.
34. Thomson G. Mapping disease genes: Family-based association studies. Am J Hum Genet. 1995; 57: 487-98.
35. Baschal EE, Aly TA, Jasinski JM et al. The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes. Diabetes Obes Metab. 2009; 11(Suppl. 1): 25-30.
36. Rubinstein P, Walker M, Carpenter C et al. Genetics of HLA-disease associations. The use of the haplotype relative risk (hrr) and the "haplo-delta" (Dh) estimates in juvenile diabetes from three racial groups. Hum Immunol. 1981; 3: 384(Abstract).
37. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21: 263-5.
38. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science. 2002; 296: 2225-9.
39. Blankenhorn EP, Cort L, Greiner DL, Guberski DL, Mordes JP. Virus-induced autoimmune diabetes in the LEW.1WR1 rat requires Iddm14 and a genetic locus proximal to the major histocompatibility complex. Diabetes. 2009; 58: 2930-8.
40. Castellanos-Rubio A, Santin I, Irastorza I et al. A regulatory single nucleotide polymorphism in the ubiquitin D gene associated with celiac disease. Hum Immunol. 2010; 71: 96-9.
41. Chiu YH, Sun Q, Chen ZJ. E1-L2 activates both ubiquitin and FAT10. Mol Cell. 2007; 27: 1014-23.
42. Kalveram B, Schmidtke G, Groettrup M. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition. J Cell Sci. 2008; 121: 4079-88.
43. Raasi S, Schmidtke G, de GR, Groettrup M. A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha. Eur J Immunol. 1999; 29: 4030-6.
44. Bates EE, Ravel O, Dieu MC et al. Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells. Eur J Immunol. 1997; 27: 2471-7.
45. Ebstein F, Lange N, Urban S, Seifert U, Kruger E, Kloetzel PM. Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int J Biochem Cell Biol. 2009; 41: 1205-15.